Evolus (EOLS) Assets (2017 - 2026)
Evolus' (EOLS) quarterly Assets came in at $220.6 million in Q1 2026, up 3.41% YoY from $213.4 million in Q1 2025, and down 2.31% on a QoQ basis from $225.9 million in Q4 2025.
Evolus (EOLS) Assets (2017 - 2026) Analysis & Trends
Evolus (EOLS) has 10 years of Assets data on file, last reported at $220.6 million in Q1 2026.
- Quarterly Assets rose 3.41% year-over-year to $220.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $220.6 million (up 3.41% YoY) and the FY2025 annual result came in at $225.9 million, down 2.88% from the prior year.
- Assets eased to $220.6 million in Q1 2026, from $225.9 million in the prior quarter.
- In the past five years, Assets ranged from a high of $233.8 million in Q2 2024 to a low of $160.2 million in Q1 2023.
- A 5-year average of $207.0 million and a median of $219.0 million in 2025 frame the typical range for Assets.
- Annual changes were most pronounced in 2022 — Assets plunged 30.88% — and 2024, when it surged 41.15%.
- Tracing EOLS's Assets over 5 years: stood at $178.0 million in 2022, then rose by 6.19% to $189.0 million in 2023, then grew by 23.05% to $232.6 million in 2024, then decreased by 2.88% to $225.9 million in 2025, then dropped by 2.31% to $220.6 million in 2026.
- The last three Assets figures came in at $220.6 million (Q1 2026), $225.9 million (Q4 2025), and $219.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.31 Bn | 43.35 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 43.88 Bn | 40.22 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 32.22 Bn | 30.54 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.85 Bn | 17.96 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 11.96 Bn | 11.43 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 6.18 Bn |
| 10 | Evolus | 546.22 Mn | 501.05 Mn | 57.18 Mn | 248.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 248.02 Mn |
| Mar 31, 2026 | 220.65 Mn |
| Dec 31, 2025 | 225.87 Mn |
| Sep 30, 2025 | 219.00 Mn |
| Jun 30, 2025 | 228.80 Mn |
| Mar 31, 2025 | 213.36 Mn |
| Dec 31, 2024 | 232.57 Mn |
| Sep 30, 2024 | 229.61 Mn |
| Jun 30, 2024 | 233.77 Mn |
| Mar 31, 2024 | 226.18 Mn |
| Dec 31, 2023 | 189.00 Mn |
| Sep 30, 2023 | 167.97 Mn |
| Jun 30, 2023 | 168.98 Mn |
| Mar 31, 2023 | 160.24 Mn |
| Dec 31, 2022 | 177.98 Mn |
| Sep 30, 2022 | 192.72 Mn |
| Jun 30, 2022 | 210.92 Mn |
| Mar 31, 2022 | 220.66 Mn |
| Dec 31, 2021 | 257.48 Mn |
| Sep 30, 2021 | 215.22 Mn |